Classical Hodgkin Lymphoma Type PTLD
1 clinical trials · Condition
◉ Watch Classical Hodgkin Lymphoma Type PTLD
| Record | Firm | Date |
|---|---|---|
| A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) (NCT04138875) | Yale University | 2022-01-01 |
Track Classical Hodgkin Lymphoma Type PTLD automatically
Every clearance here is in the API, with alerts when new ones post.